Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPSP795 in Autosomal Dominant Hypocalcemia
NCT02204579Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NPSP795 in autosomal dominant hypocalcemia type 1 (ADH1), sponsored by Takeda. Started Jul 2014; status: completed.
02
Drugs
NPSP795
03
Conditions
autosomal dominant hypocalcemia type 1 (ADH1)
Beyond the preview
Go deeper on NCT02204579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02204579.